STRS Ohio’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.84M Sell
122,821
-7,603
-6% -$627K 0.04% 384
2025
Q4
$11.1M Sell
130,424
-5,251
-4% -$431K 0.04% 378
2025
Q3
$10.6M Sell
135,675
-4,776
-3% -$373K 0.04% 392
2025
Q2
$11M Buy
140,451
+9,578
+7% +$714K 0.04% 379
2025
Q1
$9.49M Sell
130,873
-4,412
-3% -$316K 0.04% 388
2024
Q4
$10M Sell
135,285
-8,096
-6% -$567K 0.04% 387
2024
Q3
$9.46M Sell
143,381
-2,428
-2% -$176K 0.04% 389
2024
Q2
$13.5M Sell
145,809
-5,755
-4% -$510K 0.05% 331
2024
Q1
$14.5M Sell
151,564
-9,856
-6% -$828K 0.06% 311
2023
Q4
$12.3M Sell
161,420
-6,685
-4% -$465K 0.05% 339
2023
Q3
$11.6M Sell
168,105
-3,517
-2% -$283K 0.05% 340
2023
Q2
$16.2M Sell
171,622
-15,196
-8% -$1.32M 0.07% 296
2023
Q1
$15.5M Sell
186,818
-16,599
-8% -$1.3M 0.07% 306
2022
Q4
$15.2M Sell
203,417
-42,385
-17% -$3.27M 0.07% 316
2022
Q3
$20.3M Sell
245,802
-1,898
-0.8% -$183K 0.1% 239
2022
Q2
$23.6M Sell
247,700
-195,357
-44% -$20.2M 0.11% 232
2022
Q1
$52.2M Buy
443,057
+2,626
+0.6% +$295K 0.19% 131
2021
Q4
$57.1M Buy
440,431
+16,891
+4% +$1.97M 0.2% 119
2021
Q3
$47.9M Sell
423,540
-75,733
-15% -$8.64M 0.18% 140
2021
Q2
$51.7M Sell
499,273
-36,898
-7% -$3.48M 0.19% 126
2021
Q1
$44.8M Sell
536,171
-260,537
-33% -$22M 0.17% 154
2020
Q4
$72.7M Sell
796,708
-35,122
-4% -$2.91M 0.28% 86
2020
Q3
$66.4M Sell
831,830
-170,726
-17% -$13.3M 0.28% 79
2020
Q2
$69.3M Sell
1,002,556
-88,049
-8% -$6.26M 0.3% 71
2020
Q1
$68.6M Buy
1,090,605
+182,859
+20% +$13.2M 0.36% 63
2019
Q4
$70.6M Sell
907,746
-51,753
-5% -$4.04M 0.3% 83
2019
Q3
$70.3M Sell
959,499
-46,677
-5% -$3.28M 0.31% 79
2019
Q2
$62M Buy
1,006,176
+209,895
+26% +$12.7M 0.28% 91
2019
Q1
$50.8M Sell
796,281
-69
-0% -$3.94K 0.23% 116
2018
Q4
$40.7M Sell
796,350
-5,937
-0.7% -$300K 0.21% 131
2018
Q3
$46.6M Sell
802,287
-46,044
-5% -$2.25M 0.2% 137
2018
Q2
$41.2M Buy
848,331
+3,672
+0.4% +$171K 0.18% 153
2018
Q1
$39.3M Sell
844,659
-11,469
-1% -$498K 0.17% 168
2017
Q4
$32.2M Sell
856,128
-24,600
-3% -$903K 0.14% 200
2017
Q3
$32.1M Hold
880,728
0.14% 201
2017
Q2
$34.7M Sell
880,728
-43,479
-5% -$1.59M 0.15% 190
2017
Q1
$29M Sell
924,207
-253,650
-22% -$7.94M 0.13% 215
2016
Q4
$36.8M Buy
1,177,857
+68,700
+6% +$2.23M 0.16% 177
2016
Q3
$44.6M Sell
1,109,157
-11,841
-1% -$446K 0.2% 145
2016
Q2
$37.3M Sell
1,120,998
-123,627
-10% -$4.23M 0.17% 169
2016
Q1
$36.6M Sell
1,244,625
-111,435
-8% -$3.07M 0.16% 179
2015
Q4
$35.7M Buy
1,356,060
+1,308,390
+2,745% +$34M 0.16% 173
2015
Q3
$1.13M Buy
47,670
+8,868
+23% +$214K 0.01% 771
2015
Q2
$921K Buy
38,802
+25,872
+200% +$584K ﹤0.01% 916
2015
Q1
$307K Buy
+12,930
New +$290K ﹤0.01% 1349
2013
Q3
Sell
-1,605,000
Closed -$18M 1853
2013
Q2
$18M Buy
+1,605,000
New +$19M 0.08% 308

Other funds holding EW

STRS Ohio's EW Position: Q1 2026 in Review

STRS Ohio reduced its Edwards Lifesciences (EW) stake by 5.8% in Q1 2026, selling an estimated $627K and leaving 122,821 shares worth $9.84M. The position accounts for 0.04% of the portfolio, ranked #384.

STRS Ohio first reported a position in EW in Q2 2013 and has held it in 46 quarters since. The position peaked at $72.7M in Q4 2020. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • STRS Ohio held 122,821 shares of Edwards Lifesciences worth $9.84M as of Q1 2026.
  • STRS Ohio sold 7,603 Edwards Lifesciences shares in Q1 2026, an estimated $627K.
  • Edwards Lifesciences made up 0.04% of STRS Ohio's portfolio in Q1 2026, its #384 holding.
  • STRS Ohio first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 46 quarters since.
  • STRS Ohio's Edwards Lifesciences position peaked at $72.7M in Q4 2020.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.